StemCells, Inc. Receives Authorization to Conduct World’s First Neural Stem Cell Trial in Spinal Cord Injury
PALO ALTO, Calif. — StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company’s proprietary HuCNS-SC product candidate in chronic spinal cord injury.
|
|
Spine Trauma (Advanced Life Support Series, Volume 6) … |
|
|
DMSO: Nature’s Healer $9.12 How to Use DMSO to Relieve Pain, Increase Circulation, Repair Tissue Damage…. |
|
|
Neurology PreTest Self-Assessment & Review, Seventh Edition (PreTest Clinical Medicine) $11.97 The student tested-and-reviewed way to prep for the neurology shelf exam and the USMLE Step 2 CK “. . . contains much of the relevant high-yield information that a student should amass during their Neurology clerkship. I believe a student that does well on the PreTest questions is set up to do well on their board of shelf exam.” — Michael Allison, Medical Student, SUNY Downstate ” . . . covers th… |
|
|
Cognitive Therapy: Applications in Psychiatric and Medical Settings $15.00 APPLICATIONS IN PSYCHIATRIC SETTINGS INCLUDE: an overview of Cognitive Therapy; Cognitive Therapy and medications as combined treatment; outpatient treatment of alcoholics; inpatient treatment of adolescents; problem solving training as a cognitive group therapy modality; Cognitive Therapy with young adult chronic patients; fully integrated in- and outpatient services in the psychiatric sector; a… |